These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19628122)

  • 1. Beta-blockers in the treatment of aortic regurgitation a new opportunity?
    Elkayam U
    J Am Coll Cardiol; 2009 Jul; 54(5):458-9. PubMed ID: 19628122
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blocker for severe aortic regurgitation?
    Ennezat PV; Ouchallal K; Banfi C; Maréchaux S
    J Heart Valve Dis; 2011 Jul; 20(4):478-9. PubMed ID: 21863667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dissecting aneurysm of the ascending aorta with aortic insufficiency: survival with pharmacological treatment].
    Liste Jiménez D; Martín Jadraque L; Ortiz Vázquez J; Torre Carballada MA; Cerezo Morales S
    Rev Esp Cardiol; 1972; 25(4):383-90. PubMed ID: 4404498
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cardiovascular features of marfan syndrome in childhood: just another manifestation or a specific entity?
    Groenink M; Mulder BJ
    Int J Cardiovasc Imaging; 2004 Aug; 20(4):269-70. PubMed ID: 15529907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta inhibitors in the treatment of chronic cardiac insufficiency, are they useful in stable but severely ill patients?].
    Martínez Martínez JA
    Medicina (B Aires); 2000; 60(5 Pt 1):665. PubMed ID: 11188912
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block?
    Filippatos G; Kremastinos DT
    Eur Heart J; 2007 May; 28(9):1170-1. PubMed ID: 17412729
    [No Abstract]   [Full Text] [Related]  

  • 7. Aortic elasticity and size are associated with aortic regurgitation and left ventricular dysfunction in tetralogy of Fallot after pulmonary valve replacement.
    Grotenhuis HB; Ottenkamp J; de Bruijn L; Westenberg JJ; Vliegen HW; Kroft LJ; de Roos A
    Heart; 2009 Dec; 95(23):1931-6. PubMed ID: 19710028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heartbeat: Beta-blockers for aortic regurgitation.
    Otto CM
    Heart; 2016 Feb; 102(3):165-7. PubMed ID: 26769375
    [No Abstract]   [Full Text] [Related]  

  • 9. beta(1)-adrenoceptor polymorphisms: deviation of clinical outcome with use of beta-blockers in ventricular dysfunction.
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):145-7. PubMed ID: 18248268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment for chronic aortic regurgitation: β-blockers--maybe not bad, but good?
    Evangelista A
    Heart; 2016 Feb; 102(3):168-9. PubMed ID: 26729694
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilators in aortic regurgitation.
    Afshinnia F
    N Engl J Med; 2006 Jan; 354(3):300-3; author reply 300-3. PubMed ID: 16422023
    [No Abstract]   [Full Text] [Related]  

  • 12. Nifedipine in severe aortic regurgitation.
    Manyari DE; Yunus A
    N Engl J Med; 1995 May; 332(19):1302-3; author reply 1303-4. PubMed ID: 7772147
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival in patients with severe aortic regurgitation and severe left ventricular dysfunction is improved by aortic valve replacement: results from a cohort of 166 patients with an ejection fraction < or =35%.
    Kamath AR; Varadarajan P; Turk R; Sampat U; Patel R; Khandhar S; Pai RG
    Circulation; 2009 Sep; 120(11 Suppl):S134-8. PubMed ID: 19752358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction and prognostic effects of left ventricular diastolic dysfunction and patient-prosthesis mismatch as determinants of outcome after isolated aortic valve replacement.
    Brown J; Shah P; Stanton T; Marwick TH
    Am J Cardiol; 2009 Sep; 104(5):707-12. PubMed ID: 19699349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine in severe aortic regurgitation.
    Klein LJ; Reichert CL; Arnold AE
    N Engl J Med; 1995 May; 332(19):1303; author reply 1303-4. PubMed ID: 7708081
    [No Abstract]   [Full Text] [Related]  

  • 17. Nifedipine in severe aortic regurgitation.
    Coats AJ
    N Engl J Med; 1995 May; 332(19):1303; author reply 1303-4. PubMed ID: 7708080
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasodilators in aortic regurgitation.
    Krasuski RA; Griffin BP
    N Engl J Med; 2006 Jan; 354(3):300-3; author reply 300-3. PubMed ID: 16422022
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
    Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
    Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midterm results of Ross aortic valve replacement: a single-institution experience.
    Brown JW; Ruzmetov M; Shahriari A; Rodefeld MD; Mahomed Y; Turrentine MW
    Ann Thorac Surg; 2009 Aug; 88(2):601-7; discussion 607-8. PubMed ID: 19632420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.